Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 2
1967 1
1968 2
1969 2
1974 3
1976 1
1979 1
1980 1
1981 1
1982 1
1984 1
1985 4
1987 2
1988 1
1989 1
2002 1
2003 1
2004 3
2006 3
2007 3
2008 5
2009 5
2010 5
2011 12
2012 14
2013 8
2014 7
2015 9
2016 10
2017 15
2018 9
2019 17
2020 9
2021 7
2022 9
2023 8
2024 2
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

157 results

Results by year

Filters applied: . Clear all
Page 1
Acceptability and tolerability of long-acting injectable cabotegravir or rilpivirine in the first cohort of virologically suppressed adolescents living with HIV (IMPAACT 2017/MOCHA): a secondary analysis of a phase 1/2, multicentre, open-label, non-comparative dose-finding study.
Lowenthal ED, Chapman J, Ohrenschall R, Calabrese K, Baltrusaitis K, Heckman B, Yin DE, Agwu AL, Harrington C, Van Solingen-Ristea RM, McCoig CC, Adeyeye A, Kneebone J, Chounta V, Smith-Anderson C, Camacho-Gonzalez A, D'Angelo J, Bearden A, Crauwels H, Huang J, Buisson S, Milligan R, Ward S, Bolton-Moore C, Gaur AH; IMPAACT 2017 Collaborators; IMPAACT 2017 Team. Lowenthal ED, et al. Among authors: heckman b. Lancet HIV. 2024 Apr;11(4):e222-e232. doi: 10.1016/S2352-3018(23)00301-6. Lancet HIV. 2024. PMID: 38538161 Clinical Trial.
Jeans folliculitis.
Heckman BH. Heckman BH. N Engl J Med. 1981 Aug 27;305(9):524. doi: 10.1056/NEJM198108273050921. N Engl J Med. 1981. PMID: 7254303 No abstract available.
Safety and pharmacokinetics of oral and long-acting injectable cabotegravir or long-acting injectable rilpivirine in virologically suppressed adolescents with HIV (IMPAACT 2017/MOCHA): a phase 1/2, multicentre, open-label, non-comparative, dose-finding study.
Gaur AH, Capparelli EV, Calabrese K, Baltrusaitis K, Marzinke MA, McCoig C, Van Solingen-Ristea RM, Mathiba SR, Adeyeye A, Moye JH, Heckman B, Lowenthal ED, Ward S, Milligan R, Samson P, Best BM, Harrington CM, Ford SL, Huang J, Crauwels H, Vandermeulen K, Agwu AL, Smith-Anderson C, Camacho-Gonzalez A, Ounchanum P, Kneebone JL, Townley E, Bolton Moore C; IMPAACT 2017 Collaborators; IMPAACT 2017 Team. Gaur AH, et al. Among authors: heckman b. Lancet HIV. 2024 Apr;11(4):e211-e221. doi: 10.1016/S2352-3018(23)00300-4. Lancet HIV. 2024. PMID: 38538160 Clinical Trial.
Tension-type headache and psychiatric comorbidity.
Heckman BD, Holroyd KA. Heckman BD, et al. Curr Pain Headache Rep. 2006 Dec;10(6):439-47. doi: 10.1007/s11916-006-0075-2. Curr Pain Headache Rep. 2006. PMID: 17087869 Review.
Pharmacokinetics, safety, and tolerability of dispersible and immediate-release abacavir, dolutegravir, and lamivudine tablets in children with HIV (IMPAACT 2019): week 24 results of an open-label, multicentre, phase 1-2 dose-confirmation study.
Brooks KM, Kiser JJ, Ziemba L, Ward S, Rani Y, Cressey TR, Masheto GR, Cassim H, Deville JG, Ponatshego PL, Patel F, Aurpibul L, Barnabas SL, Mustich I, Coletti A, Heckman B, Krotje C, Lojacono M, Yin DE, Townley E, Moye J, Majji S, Acosta EP, Ryan K, Chandasana H, Brothers CH, Buchanan AM, Rabie H, Flynn PM; IMPAACT 2019 Study Team. Brooks KM, et al. Among authors: heckman b. Lancet HIV. 2023 Aug;10(8):e506-e517. doi: 10.1016/S2352-3018(23)00107-8. Lancet HIV. 2023. PMID: 37541705 Free PMC article. Clinical Trial.
Initial Validation of the Intentions to Co-Use Alcohol and Opioids Scale.
Powers JM, Lape EC, LaRowe LR, Hooker JE, Heckman BW, Ditre JW. Powers JM, et al. Among authors: heckman bw. J Psychoactive Drugs. 2023 Jul-Aug;55(3):369-377. doi: 10.1080/02791072.2022.2075713. Epub 2022 May 15. J Psychoactive Drugs. 2023. PMID: 35574916 Free PMC article.
Behavioral Outcomes of Nicotine Reduction in Current Adult Smokers.
Smith TT, Heckman BW, Tidey JW, Colby SM, Cummings KM. Smith TT, et al. Among authors: heckman bw. Nicotine Tob Res. 2019 Dec 23;21(Suppl 1):S125-S127. doi: 10.1093/ntr/ntz102. Nicotine Tob Res. 2019. PMID: 31867649 Free PMC article. No abstract available.
157 results